Cargando…
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
BACKGROUND: Urokinase-type plasminogen activator (uPA) plays a major role in extracellular proteolytic events associated with tumor cell growth, migration and angiogenesis. Consequently, uPA is an attractive target for the development of small molecule active site inhibitors. Most of the recent drug...
Autores principales: | Heynekamp, Justin J, Hunsaker, Lucy A, Vander Jagt, Thomas A, Deck, Lorraine M, Vander Jagt, David L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1479381/ https://www.ncbi.nlm.nih.gov/pubmed/16466576 http://dx.doi.org/10.1186/1472-6769-6-1 |
Ejemplares similares
-
Substituted trans-stilbenes can inhibit or enhance the TPA-induced up-regulation of activator protein-1
por: Deck, Lorraine M, et al.
Publicado: (2008) -
Inhibition of pancreatic cholesterol esterase reduces cholesterol absorption in the hamster
por: Heidrich, John E, et al.
Publicado: (2004) -
A Chemical Analog of Curcumin as an Improved Inhibitor of Amyloid Abeta Oligomerization
por: Orlando, Robert A., et al.
Publicado: (2012) -
Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors
Publicado: (1987) -
Localization of Urokinase‐type Plasminogen Activator, Plasminogen Activator Inhibitor‐1, 2 and Plasminogen in Colon Cancer
por: Naitoh, Hiroyuki, et al.
Publicado: (1995)